Pirfenidone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04951 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | extracutaneous mastocytoma | KG + DL |
| 2 | dermatofibrosarcoma protuberans | KG + DL |
| 3 | aggressive systemic mastocytosis | KG + DL |
| 4 | heart fibrosarcoma | KG + DL |
| 5 | conventional fibrosarcoma | KG + DL |
| 6 | autosomal recessive familial Mediterranean fever | KG + DL |
| 7 | kidney fibrosarcoma | KG + DL |
| 8 | hepatic infarction | KG + DL |
| 9 | fibroblastic neoplasm | KG + DL |
| 10 | low grade fibromyxoid sarcoma | KG + DL |
| 11 | hepatic veno-occlusive disease | KG + DL |
| 12 | peliosis hepatis | KG + DL |
| 13 | Kimura disease | KG + DL |
| 14 | syndrome with combined immunodeficiency | KG + DL |
| 15 | X-linked lymphoproliferative syndrome | KG + DL |
| 16 | leishmaniasis, diffuse cutaneous | KG + DL |
| 17 | familial rhabdoid tumor | KG + DL |
| 18 | Castleman disease | KG + DL |
| 19 | benign PEComa | KG + DL |
| 20 | lymphangiomyoma | KG + DL |
| 21 | uterine corpus perivascular epithelioid cell tumor | KG + DL |
| 22 | ovarian myxoid liposarcoma | KG + DL |
| 23 | Kaposi’s sarcoma (disease) | KG + DL |
| 24 | liposarcoma | KG + DL |
| 25 | cryptogenic organizing pneumonia | KG + DL |
| 26 | hemophagocytic syndrome associated with an infection | KG + DL |
| 27 | acquired hemophagocytic lymphohistiocytosis associated with malignant disease | KG + DL |
| 28 | cutaneous undifferentiated pleomorphic sarcoma | KG + DL |
| 29 | cutaneous leiomyosarcoma (disease) | KG + DL |
| 30 | central nervous system fibrosarcoma | KG + DL |
| 31 | desquamative interstitial pneumonia | KG + DL |
| 32 | aleukemic mast cell leukemia | KG + DL |
| 33 | bone fibrosarcoma | KG + DL |
| 34 | combined pulmonary fibrosis-emphysema syndrome | KG + DL |
| 35 | idiopathic pleuroparenchymal fibroelastosis | KG + DL |
| 36 | non-specific interstitial pneumonia | KG + DL |
| 37 | liver fibrosarcoma | KG + DL |
| 38 | lymphoid interstitial pneumonia | KG + DL |
| 39 | familial Mediterranean fever | KG + DL |
| 40 | gallbladder leiomyosarcoma | KG + DL |
| 41 | autosomal dominant familial periodic fever | KG + DL |
| 42 | vulva sarcoma | KG + DL |
| 43 | breast fibrosarcoma | KG + DL |
| 44 | mastocytosis | KG + DL |
| 45 | indolent systemic mastocytosis | KG + DL |
| 46 | hepatic vein thrombosis | KG + DL |
| 47 | uterine corpus myxoid leiomyosarcoma | KG + DL |
| 48 | relapsing-remitting multiple sclerosis | KG + DL |
| 49 | periodic fever-infantile enterocolitis-autoinflammatory syndrome | KG + DL |
| 50 | uterine corpus epithelioid leiomyosarcoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.